
Phd hab Łukasz Opaliński
professor
Zakład Biotechnologii Medycznej
Head the doctoral college of the doctoral school
Faculty of Biotechnology
lukasz.opalinski@uwr.edu.pl
tel. +48 71 375 26 31
Interested
- biochemistry molecular biology
- chemical physics
- signaling
- biotechnology
- polymers
- fgf12
- galectin 8
- immunology
- crd
- fgfs
Scientific discipline
- medical sciences
- biotechnology
Latest publications
- Multivalent protein-drug conjugates – an emerging strategy for the upgraded precision and efficiency of drug delivery to cancer cells
- FHF1 is a bona fide fibroblast growth factor that activates cellular signaling in FGFR-dependent manner.
- Differential regulation of fibroblast growth factor receptor 1 trafficking and function by extracellular galectins.
- Cross-talk between fibroblast growth factor receptors and other cell surface proteins.
- Stable fibroblast growth factor 2 dimers with high pro-survival and mitogenic potential.
- Intrinsically fluorescent oligomeric cytotoxic conjugates toxic for FGFR1-overproducing cancers.
- Low stability of integrin-binding deficient mutant of FGF1 restricts its biological activity.
- IRE1-mediated degradation of pre-miR-301a promotes apoptosis through upregulation of GADD45A
- Crosstalk between p38 and Erk 1/2 in downregulation of FGF1-induced signaling.
- FGF2-derived peptibodyF2-MMAE conjugate for targeted delivery of cytotoxic drugs into cancer cells overexpressing FGFR1.
- FGF/FGFR-dependent molecular mechanisms underlying anti-cancer drug resistance.
- Novel method for preparation of site-specific, stoichiometric-controlled dual warhead conjugate of FGF2 via dimerization employing sortase a-mediated ligation.
- FGFR1 clustering with engineered tetravalent antibody improves the efficiency and modifies the mechanism of receptor internalization.
- Targeting cellular trafficking of fibroblast growth factor receptors as a strategy for selective cancer treatment.
- N-glycosylation acts as a switch for FGFR1 trafficking between the plasma membrane and nuclear envelope
- Galectins as modulators of receptor tyrosine kinases signaling in health and disease
- Receptor clustering by a precise set of extracellular galectins initiates FGFR signaling
- The Significance of Cell Surface N-Glycosylation for Internalization and Potency of Cytotoxic Conjugates Targeting Receptor Tyrosine Kinases
- FGF homologous factors are secreted from cells to induce FGFR‐mediated anti‐apoptotic response
- Glycosylation of FGF/FGFR: An underrated sweet code regulating cellular signaling programs